- Home
- ZNTL vs STKE Comparison
ZNTL vs STKE Comparison
Compare ZNTL & STKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- STKE
- Stock Information
- Founded
- ZNTL 2014
- STKE 2002
- Country
- ZNTL United States
- STKE Canada
- Employees
- ZNTL N/A
- STKE N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- STKE
- Sector
- ZNTL Health Care
- STKE
- Exchange
- ZNTL Nasdaq
- STKE Nasdaq
- Market Cap
- ZNTL 118.3M
- STKE 95.8M
- IPO Year
- ZNTL 2020
- STKE N/A
- Fundamental
- Price
- ZNTL $1.35
- STKE $3.06
- Analyst Decision
- ZNTL Buy
- STKE
- Analyst Count
- ZNTL 6
- STKE 0
- Target Price
- ZNTL $6.53
- STKE N/A
- AVG Volume (30 Days)
- ZNTL 772.7K
- STKE 680.1K
- Earning Date
- ZNTL 11-10-2025
- STKE 01-29-2026
- Dividend Yield
- ZNTL N/A
- STKE N/A
- EPS Growth
- ZNTL N/A
- STKE N/A
- EPS
- ZNTL N/A
- STKE N/A
- Revenue
- ZNTL $26,865,000.00
- STKE $14,342,517.00
- Revenue This Year
- ZNTL N/A
- STKE $43.15
- Revenue Next Year
- ZNTL N/A
- STKE $39.60
- P/E Ratio
- ZNTL N/A
- STKE N/A
- Revenue Growth
- ZNTL N/A
- STKE N/A
- 52 Week Low
- ZNTL $1.01
- STKE $2.71
- 52 Week High
- ZNTL $4.44
- STKE $34.32
- Technical
- Relative Strength Index (RSI)
- ZNTL 41.00
- STKE N/A
- Support Level
- ZNTL $1.25
- STKE N/A
- Resistance Level
- ZNTL $1.41
- STKE N/A
- Average True Range (ATR)
- ZNTL 0.10
- STKE 0.00
- MACD
- ZNTL -0.02
- STKE 0.00
- Stochastic Oscillator
- ZNTL 23.71
- STKE 0.00
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About STKE Sol Strategies Inc. Common Shares
Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.